| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |